Vilin BIO MED Limited

NSE: VILINBIO · Other · sector

₹50.90NSE close 2026-10-26

Key numbers

Market cap₹78 cr

Price₹50.90

52w high / low₹61 / ₹19

P/E37.2xSector median 14.4x

P/B5.9xSector median 1.7x

Book value₹8.6

Dividend yield–Sector median 0.37%

ROE17.4%Sector median 13.8%

ROCE22.2%Sector median 19.6%

OPM7.6%Sector median 10.4%

Debt / equity–Sector median 0.29x

EV/EBITDA23.9xSector median 8.4x

Interest cover42.3x

Current ratio4.25x

Sales growth 3y–Sector median +7.7%

Profit growth 3y–Sector median +16.6%

PEG–

Last 12 months to Mar 2026, Standalone. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Operating profit covered interest 42.3x in the last 12 months.
Operating cash flow was below net profit in 3 of the last 3 years (FY26, FY25, FY24).
Net loss in 1 of the last 6 quarters.
Other income was 0% of net profit in the last 12 months.
No dividend in the last 3 financial years.
Price ₹50.90 on 2026-10-26: -16.5% from the 52-week high, +168.6% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹60.00 · low ₹17.45

Quarterly results

₹ cr	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Revenue	8	8	4	10	10	33
EBITDA	1	-1	0	0	0	3
OPM %	18.2%	-7.0%	9.4%	3.6%	3.5%	8.8%
Other income	0	0	0	0	0	0
Net profit	1	-1	0	0	0	2
EPS (₹)	0.55	0.00	0.00	0.07	0.11	1.26
Revenue YoY					+26.3%	+299.5%
Profit YoY					-80.5%	–

Standalone figures where filed. Latest quarter Mar 2026.

Profit & loss (yearly)

₹ cr	FY24	FY25	FY26	TTM
Revenue	16	15	42	42
EBITDA	1	1	3	3
Net profit	0	0	2	2
EPS (₹)	0.12	0.16	1.37	1.37
Revenue growth		-6.3%	+185.3%	–
Profit growth		+37.5%	+777.3%	–
Dividend / share (₹)	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	–	–	–
Net profit	–	–	–
EPS	–	–	–
Share price	–	+46.0% (2y)	+92.6%

Balance sheet

₹ cr	FY24	FY25	FY26
Shareholders' equity	–	9	13
Cash & equivalents	–	0	1
Total assets	–	28	35
Fixed assets	–	1	3
Investments	–	0	0
Inventory	–	4	7

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY24	FY25	FY26
Cash from operations	-5	-4	1
Cash from investing	0	-1	-0
Cash from financing	11	-1	1
Capex	0	2	0
Free cash flow	-5	-5	0

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY24	FY25	FY26
ROE %	–	2.5%	14.7%
ROCE %	–	12.6%	22.2%
Inventory days	–	120	70
Working capital days	–	197	181

Peers in Other

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
TSFINV	₹8,585 cr	17.6x	1.4x	8.4%	3.6%	20.5%	+121.7%	2.30%
KRISHANA	₹6,339 cr	39.9x	11.3x	41.6%	23.2%	12.6%	+95.7%	0.05%
MARINE	₹5,431 cr	84.2x	11.0x	14.3%	18.0%	10.8%	+25.6%	0.07%
ZOTA	₹4,139 cr	–	6.0x	-22.5%	-12.4%	-0.5%	+56.7%	0.07%
AIMTRON	₹3,319 cr	71.7x	17.1x	28.0%	31.8%	21.8%	–	–
ACCORD	₹2,984 cr	–	261.7x	12.4%	12.0%	2.4%	–	–
MONOLITH	₹2,646 cr	64.6x	24.3x	36.0%	48.7%	24.4%	–	–
UTSSAV	₹2,390 cr	40.2x	14.1x	43.4%	54.7%	7.9%	–	–
BETA	₹2,200 cr	40.6x	5.0x	16.4%	17.0%	20.8%	–	–
VILINBIO	₹78 cr	37.2x	5.9x	17.4%	22.2%	7.6%	–	–

All 688 companies in Other →

Documents

Links go to the original files on the exchange website.

About the company


Sector
Industry	Other
Sub-industry
Symbol	VILINBIO
BSE code	–
ISIN	INE0L4V01013
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-26.